Risk And Protective Factors For Sga-Induced Metabolic Syndrome In Bipolar Youth
Posted Date: May 15, 2019
- Investigator: Robert Mcnamara
- Type of Study: Drug
The first purpose of this study is to identify risk factors associated with developing cardiometabolic symptoms and weight gain after taking Quetiapine. Cardiometabolic risk refers to your chances of developing diabetes, elevated blood lipids, and heart disease. Quetiapine is approved by the U
Criteria:
Your Child Is Being Asked To Take Part In This Research Study Because He/She Is 10 To 17 Years Of Ag
Keywords:
Quetiapine, Adolescent, Bipolar, Seroquel, Omega 3
For More Information:
Lauren Miller
513-558-4112
milleln@ucmail.uc.edu